Scout Investments Inc. lowered its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 282,400 shares of the specialty pharmaceutical company’s stock after selling 4,429 shares during the period. Scout Investments Inc. owned approximately […]
Congress Wealth Management LLC DE trimmed its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 18.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 129,051 shares of the specialty pharmaceutical company’s stock after selling 30,095 shares during the quarter. Congress […]
Mach 1 Financial Group LLC purchased a new position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 14,554 shares of the specialty pharmaceutical company’s stock, valued at approximately $421,000. A number of other institutional […]
Lazard Asset Management LLC increased its position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 170.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,905 shares of the specialty pharmaceutical company’s stock after purchasing an additional 7,508 shares […]
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Get Free Report) SVP Frank Mottola sold 1,110 shares of the business’s stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $28.13, for a total value of $31,224.30. Following the sale, the senior vice president now owns 5,681 shares of […]